Use of Gynecological Drugs Restricted In EU; ‘Urgent’ Safety Review Starts For Pholcodine

A Review Has Also Started For Topiramate

The European Medicines Agency has completed its investigation into the safety of nomegestrol and chlormadinone, and has started reviewing risks linked to the cough suppressant, pholcodine, and the epilepsy and migraine drug, topiramate.

Wooden blocks with the word Review. Customer review concept. Reviewing, auditing, reviewer. Service rating. Feedback.
Safety reviews are under way for pholcodine and topiramate • Source: Almay

Restrictions are to be placed on the use of drugs containing high doses of nomegestrol or chlormadinone in the EU after the European Medicines Agency concluded that these medicines, which are used to treat gynecological disorders, can increase the risk of meningioma.

In addition, the EMA has started an urgent review of the safety of the cough suppressant, pholcodine, as well as...

More from Post-Marketing Regulation & Studies

US FDA Advisory Committee Supports Vaccine Safety, Scrutinizes AE Reporting Quality

 
• By 

The Pediatric Advisory Committee supported routine safety monitoring for three vaccines and 21 drugs, but the panel’s consumer representative said adverse event reporting needs improvement and FDA literature reviews should include lawsuits as well as social media.

CAR-T REMS Removal Should Boost Access, But Long-Term Follow-Up, Black Box Remain

 

The REMS removal and labeling changes should open up CAR-T treatment to many more US patients, although other regulatory hurdles and safety language that experts had wanted removed still stand.

EMA Touts Faster Global Post-Approval Changes Via Regulatory Reliance

 

The European Medicines Agency says that a regulatory reliance pilot that it is supporting to speed up assessments of post-approval changes appears to be accelerating evaluation timelines in non-EU countries.

Novavax’s COVID-19 Vaccine Label Narrowed After Political Officials Intervened

 

The label that Novavax's COVID-19 vaccine was slated to receive before political officials held up the approval was broader than was granted 16 May.

More from Product Reviews